| Literature DB >> 35757477 |
Erliang Kong1,2, Lun Shu2, Chang Yuan3, Jianxin Wang1, Feixiang Wu4, Hongbin Yuan2, Xudong Feng1.
Abstract
Objective: Pediatric patients are facing greater difficulties in radial catheterization for anatomic variation and smaller diameter. This study is to investigate the efficacy of phentolamine accompanied by lidocaine subcutaneously under ultrasound guidance on radial catheterization in pediatric patients.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35757477 PMCID: PMC9225856 DOI: 10.1155/2022/6554993
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Flow diagram of grouping.
Baseline characteristics of pediatric patients.
| Characteristics | Saline group ( | Phentolamine group ( | Phentolamine+lidocaine group ( |
|
|---|---|---|---|---|
| Age (months) | 12.06 ± 4.68 | 10.28 ± 4.04 | 11.95 ± 4.05 | 0.469 |
| Sex (male/female) | 8/9 | 10/8 | 11/9 | 0.853 |
| Weight (kg) | 9.26 ± 1.63 | 9.01 ± 3.09 | 9.32 ± 3.03 | 0.932 |
| ASA (%) | 0.862 | |||
| I | 7 (41.18%) | 6 (33.33%) | 7 (35.00%) | |
| II | 7 (41.18%) | 9 (50.00%) | 10 (50.00%) | |
| III | 3 (17.65%) | 3 (33.33%) | 2 (10.00%) | |
| IV | 0 (0%) | 0 (0%) | 1 (5.00%) | |
| V | 0 (0%) | 0 (0%) | 0 (0%) | |
| SBP (mmHg) | 83.53 ± 8.27 | 79.33 ± 9.37 | 82.15 ± 10.37 | 0.410 |
| DBP (mmHg) | 53.47 ± 6.79 | 52.06 ± 8.56 | 52.40 ± 6.78 | 0.842 |
| Heart rate (min−1) | 108.71 ± 14.41 | 106.28 ± 13.44 | 103.45 ± 12.36 | 0.494 |
| Hemoglobin (g/dl) | 11.44 ± 1.15 | 11.14 ± 1.56 | 11.08 ± 1.91 | 0.778 |
ASA: American Society of Anesthesiologists; SBP: systolic blood pressure; DBP: diastolic blood pressure.
Surgical types.
| Surgical types, | Saline group ( | Phentolamine group ( | Phentolamine+lidocaine group ( |
|
|---|---|---|---|---|
| Neurosurgery | 3 (17.65%) | 2 (11.11%) | 3 (15.00%) | 0.997 |
| Cardiac surgery | 9 (52.94%) | 9 (50.00%) | 10 (50.00%) | |
| General surgery | 3 (17.65%) | 4 (22.22%) | 3 (15.00%) | |
| Urinary surgery | 1 (5.88%) | 2 (11.11%) | 2 (10.00%) | |
| Others | 1 (5.88%) | 1 (5.56%) | 2 (10.00%) |
Changes of radial artery diameter.
| Variables | Saline group ( | Phentolamine group ( | Phentolamine+lidocaine group ( |
|
|---|---|---|---|---|
| Diameter before injection (mm) | 1.16 ± 0.11 | 1.16 ± 0.10 | 1.17 ± 0.10 | 0.906 |
| Diameter after injection (mm) | 1.13 ± 0.12 | 1.26 ± 0.15 | 1.32 ± 0.13 | <0.01 |
|
| 0.303 | 0.037 | <0.01 | |
| Diameter after catheterization (mm) | 1.14 ± 0.11 | 1.28 ± 0.10 | 1.35 ± 0.09 | <0.01 |
| Percentage change of diameter before and after injection (%) | 2.00 ± 0.13 | 10.00 ± 0.17 | 13.00 ± 0.17 | <0.01 |
Changes of radial artery depth.
| Variables | Saline group ( | Phentolamine group ( | Phentolamine+lidocaine group ( |
|
|---|---|---|---|---|
| Depth before injection (mm) | 2.86 ± 0.11 | 2.83 ± 0.15 | 2.89 ± 0.17 | 0.561 |
| Depth after injection (mm) | 3.38 ± 0.16 | 3.29 ± 0.25 | 3.19 ± 0.32 | 0.091 |
|
| <0.01 | <0.01 | <0.01 | |
| Depth after catheterization (mm) | 3.42 ± 0.23 | 3.32 ± 0.21 | 3.22 ± 0.31 | 0.072 |
Radial artery catheterization data.
| Variables | Saline group ( | Phentolamine group ( | Phentolamine+lidocaine group ( |
|
|---|---|---|---|---|
| First-attempt success rate (%) | 10 (58.82%) | 16 (88.89%) | 18 (90.00%) | 0.032 |
| Procedure time to success within the first attempt (s) | 56.50 ± 7.62 | 47.21 ± 7.43 | 42.71 ± 7.71 | <0.01 |
| Second-attempt success rate within 10 min (%) | 14 (82.35%) | 16 (88.89%) | 18 (90.00%) | 0.761 |
| Procedure time to success within the second attempt (s) | 61.79 ± 11.12 | 49.19 ± 9.59 | 43.67 ± 8.52 | <0.01 |
| Use of another artery (%) | 3 (17.65%) | 2 (11.11%) | 2 (10.00%) | 0.761 |
| Overall procedure time of arterial cannulation (s) | 66.53 ± 14.72 | 53.33 ± 15.13 | 48.35 ± 16.53 | <0.01 |
| Overall numbers of attempts | 1.65 ± 0.93 | 1.33 ± 0.69 | 1.25 ± 0.64 | 0.262 |
Figure 2Kaplan–Meier analysis for the overall procedure time to successful cannulation.
Complications of radial artery catheterization.
| Variables | Saline group ( | Phentolamine group ( | Phentolamine+lidocaine group ( |
|
|---|---|---|---|---|
| Vasospasm (%) | 6 (35.29%) | 2 (11.11%) | 1 (5.00%) | 0.035 |
| Hematoma (%) | 6 (35.29%) | 3 (16.67%) | 3 (15.00%) | 0.268 |
| Distal ischemia (%) | 2 (11.76%) | 1 (5.56%) | 1 (5.00%) | 0.691 |
| Hypotension within 20 min after subcutaneous injection (%) | 0 (0%) | 0 (0%) | 0 (0%) | |
| Overall complications | 14 | 6 | 5 | <0.01 |